Characteristics and Costs of NASH Advanced Fibrosis and Cirrhosis in Patients with and without Diabetes Mellitus (DM): Results of a US Real-World Cohort Study

被引：0

作者：

Sanyal, Arun J. ^{[1
]}

Bengtson, Lindsay ^{[2
]}

Shreay, Sanatan ^{[3
]}

Kim, W. Ray ^{[4
]}

机构：

[1] Virginia Commonwealth Univ, Richmond, VA USA

[2] Optum, Eden Prairie, MN USA

[3] Gilead Sci, HEOR, Foster City, CA USA

[4] Stanford Univ, Palo Alto, CA 94304 USA

来源：

HEPATOLOGY | 2017年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2210

引用

页码：1168A / 1169A

页数：2

共 50 条

[41] A real-world study of treating advanced liver cirrhosis due to chronic HCV infection genotype 1b with sofosbuvir plus ledipasvir with or without ribavirin: results from a cohort of 349 patients
Preda, Carmen Monica
Gheorghe, Liana
Istratescu, Doina
Manuc, Mircea
Pop, Corina
Andreea, Grigore
Iacob, Speranta
Manuc, Teodora
Tugui, Letita
Tieranu, Cristian
Diculescu, Mircea Mihai
Iliescu, Elena Laura
JOURNAL OF HEPATOLOGY, 2020, 73 : S334 - S334
[42] Real-world evaluation of PARP inhibitor tolerability in advanced ovarian cancer: Retrospective US cohort study
Simmons, Daniel
Blank, Stephanie
Nagar, Saurabh
Nham, Tram
Long, Grainne
Davis, Keith
Wetherill, Graham
Munley, Jiefen
McLaurin, Kimmie
GYNECOLOGIC ONCOLOGY, 2023, 176 : S262 - S263
[43] Insulin use and gout risk among patients with type 2 diabetes mellitus: a real-world cohort study in Shanghai, China
Qi, Jiying
He, Ping
Yao, Huayan
Sun, Wen
Lu, Ping
Qi, Xiaohui
Zhang, Zizheng
Jing, Renjie
Cui, Bin
Liu, Dongmei
Ning, Guang
CLINICAL RHEUMATOLOGY, 2023, 42 (11) : 3067 - 3073
[44] The association of diabetes mellitus and routinely collected patient-reported outcomes in patients with cancer. A real-world cohort study
Ose, Dominik J.
Adediran, Emmanuel
Mark, Bayarmaa
Ocier, Krista
Dunson, William A.
Turner, Cindy
Taylor, Belinda
Svoboda, Kim
Post, Andrew R.
Leiser, Jennifer
Colman, Howard
Ulrich, Cornelia M.
Hashibe, Mia
CANCER MEDICINE, 2024, 13 (20):
[45] Real-World Unmet Needs in Patients with Hemophilia A without Inhibitors in the US: Results from the PicnicHealth Database
Thornburg, Courtney
Wheeler, Allison P.
Bozzi, Sylvie
Miles, Gandarvaka
Hawaldar, Kalyani
Wilson, Andrew
Hanson, Gillian
Liao, Noelle
Wilson, Amanda
BLOOD, 2023, 142
[46] THE USE OF SOFOSBUVIR BASED REGIMENS AMONGST TREATMENT NAIVE AND EXPERIENCED PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS: REAL WORLD RESULTS FROM A DIFFICULT TO TREAT COHORT
Sutherland, D.
Datta, S.
Forrest, E. H.
Fox, R.
Heydtmann, M.
Priest, M.
Mills, P. R.
Morris, J.
Stanley, A. J.
Barclay, S. T.
JOURNAL OF HEPATOLOGY, 2015, 62 : S664 - S665
[47] THE USE OF SOFOSBUVIR BASED REGIMENS AMONGST TREATMENT NAIVE AND EXPERIENCED PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS: REAL WORLD RESULTS FROM A DIFFICULT TO TREAT COHORT
Sutherland, D.
Forrest, E.
Heydtmann, M.
Priest, M.
Mills, P. R.
Morris, J.
Stanley, A.
Fox, R.
Barclay, S.
GUT, 2015, 64 : A57 - A58
[48] The clinical characteristics and prognosis of patients with SAPHO syndrome--a real-world cohort study
Duan, Hongji
Gao, Shuang
Zhang, Lihua
Song, Le
Zhai, Jiayu
Deng, Xiaoli
CLINICAL RHEUMATOLOGY, 2024, 43 (01) : 561 - 568
[49] Real-World Demographic and Clinical Characteristics of Patients Initiating Avatrombopag in the US: The Real-AVA Study
Kolodny, Scott
Oladapo, Abiola
Vredenburg, Michael
Jamieson, Brian
Swallow, Elyse
Goldschmidt, Debbie
Zichlin, Miriam L.
Lopez, Priscilla
Davidson, Mikhail
Yee, John
BLOOD, 2022, 140 : 13150 - 13151
[50] CHARACTERIZING THE MANAGEMENT OF PATIENTS WITH NASH (WITH VERSUS WITHOUT CIRRHOSIS) IN REAL-WORLD CLINICAL PRACTICE: RARE ASSESSMENT BY HEPATOLOGISTS AND LOW FREQUENCY OF IMAGING
Qian, Christina
Charlton, Michael R.
Szabo, Shelagh M.
Sun, Rosie
Rochon, Hannah
Fishman, Jesse
HEPATOLOGY, 2023, 78 : S927 - S928

← 1 2 3 4 5 →